21 abstracts from across the Company’s portfolio highlight clinical and real-world data on major depressive disorder, treatment-resistant depression and schizophrenia. New Phase 3 data demonstrate the safety and efficacy of… Read More
FRANKLIN LAKES, N.J. – BD (Becton, Dickinson and Company) a leading global medical technology company, expanded their Class I voluntary recall to include 15 additional impacted BD Alaris™ pump infusion… Read More
The transaction adds larsucosterol, an FDA Breakthrough Therapy for alcohol-associated hepatitis with a registrational Phase 3 clinical trial in development, to Bausch Health’s hepatology pipeline. LAVAL, QC, and CUPERTINO, CA … Read More
In health care environments, every touchpoint carries risk. Traditional high-touch surfaces — from elevator buttons to surgical monitors — can harbor pathogens and increase the risk of infection transmission. This… Read More
Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline to clinic Cytiva, a Danaher company and a global leader… Read More
